Lombard Odier Asset Management (Switzerland)’s Editas Medicine EDIT Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-242,248	Closed	-$2.15M	–	405
2022 Q4	$2.15M	Hold	242,248	–	–	0.17%	115
2022 Q3	$2.96M	Sell	242,248 -17,584	-7%	-$274K	0.25%	94
2022 Q2	$3.07M	Sell	259,832 -121,131	-32%	-$1.62M	0.26%	93
2022 Q1	$7.25M	Buy	380,963 +67,641	+22%	+$1.26M	0.57%	52
2021 Q4	$8.32M	Buy	313,322 +104,818	+50%	+$3.61M	0.53%	56
2021 Q3	$8.56M	Sell	208,504 -94,629	-31%	-$5.18M	0.53%	67
2021 Q2	$17.2M	Buy	303,133 +113,939	+60%	+$4.21M	0.87%	49
2021 Q1	$7.95M	Buy	+189,194	New	+$10.8M	0.53%	61

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s EDIT Position: Q1 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 242,248 shares — an estimated $2.15M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in EDIT in Q1 2021 and held it in 8 quarters. The position peaked at $17.2M in Q2 2021. 235 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 242,248 Editas Medicine shares in Q1 2023, an estimated $2.15M.
Lombard Odier Asset Management (Switzerland) first reported a position in Editas Medicine in Q1 2021 and held it in 8 quarters.
Lombard Odier Asset Management (Switzerland)'s Editas Medicine position peaked at $17.2M in Q2 2021.
235 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 15 May 2023.